MME and hydrops fetalis: Discuss the various pharmacotherapies available for HF with reduced EF with a predominant emphasis on three specific classes of drugs - BBs, ACEI/ARBs, and neprilysin inhibitors, with respect to patient factors, mortality benefits, and side effects.